Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Lin Xichen
Lin Xichen (SEC CIK 0001962926) files insider reports with the SEC as CHIEF SCIENTIFIC OFFICER of Structure Therapeutics Inc. (GPCR).
Signal8 holds 10 ownership filings by Lin Xichen, all Form 4s, filed between Mar 18, 2025 and Sep 2, 2026. Those filings report 27 transactions, the latest on Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lin Xichen's filings is in SOUTH SAN FRANCISCO, CA.
Other insiders filing for Structure Therapeutics Inc. (GPCR)
- Coll Crespo Blas, CHIEF MEDICAL OFFICER
- Berrios John Joseph, Chief Commercial Officer
- FMR LLC, 10% Owner
- Russell Angus C., Director
- LOVE TED W, Director
- Waldstreicher Joanne, Director